Executive Board

President, CEO: Jean-Claude Maurel – MD

Jean-Claude is the founder of Medesis Pharma and brings more than 30 years of experience in the research and development and commercialization of novel pharmaceutical product.

After founding in 1985, Natura Medica, a pharmaceutical company commercialising natural product assets, , the company was acquired in 1990 by Ipsen-Beaufour. In 1991, he created a research company that after 10 years of chemical and pharmacological explorations, discovered the lipid constituents which are today the basis of the Aonys® technology.

In 2003, he created Medesis Pharma by consolidating previous patents and know-how.

Alexandre Lemoalle – Member of the Executive Board, Director of Strategic Partnerships

Managing Partner at Finpact, an M&A and capital raising advisory firm, Alexandre Lemoalle is also a member of the Board of Directors of Iktos, a French start-up in artificial intelligence and founder of Blueming Advisory, a corporate finance advisory firm. With 20 years of experience at Sanofi from 1994 to 2014, he is a member of the Executive Board of Medesis Pharma.

Solène Guilliot – Member of the Executive Board, Director of Medical Affairs and Clinical Development

Solène Guilliot is a PharmD with over 7 years of experience in Medical Affairs and Clinical Development. Previously, she had several international positions in medical affairs with Sanofi Genzyme and Bristol-Myers Squibb (U.S.A, Canada, Germany and France). With a strong background in Neuroscience and Immunology, in industry and hospital, she joined Medesis Pharma in 2021.

Tessa Olivato – Member of the Executive Board, Administrative and Financial Director

With more than 20 years of experience, including 10 years as an executive assistant in an international drilling company, Tessa Olivato, a French-Belgian national, joined Medesis Pharma in 2014. In June 2021, she took up the position of Administrative and Financial Director.

Supervisory Board

Olivier Connes – Chairman of the Supervisory Board:

Olivier Connes is Chairman of the Executive Board of Meridis Group, an industrial equipment supplier focused on furnishings, food processing and research. He is a partner at Solid Surfaces Applications, a company specializing in wood and PVC joinery.

Bernard Connes – Member and Vice-Chairman of the Supervisory Board:

Bernard Connes is a member and Vice-Chairman of the Supervisory Board of Medesis Pharma. He is manager of several companies, including Eolienne and Athanor, based in Montpellier and operating in the real estate sector. He is also co-manager of Solid Surfaces Applications, a company specializing in wood and PVC joinery, and of Adam.

Jean-Marie Cazalèdes – Member of the Supervisory Board:

Currently retired after nearly 30 years as a pharmacist at the Cazalèdes Pharmacy in Beaucaire (30300), Jean-Marie Cazalèdes is a member of the Supervisory Board.

Cédric Navas – Member of the Supervisory Board:

Manager of NAVAS PATRIMOINE, a wealth management firm, and President of the Association Ethique & Patrimoine, which groups 28 wealth management firms, Cédric Navas is a member of the Supervisory Board of Medesis Pharma.

Jean-Philippe Causse – Member of the Supervisory Board:

Director of network development as a wealth management consultant since 1992, Jean-Philippe Causse is a member of the Supervisory Board of Medesis Pharma